13 Tue
All-day
12:00 am
1:00 am
2:00 am
3:00 am
4:00 am
5:00 am
6:00 am
7:00 am
8:00 am
9:00 am
10:00 am
11:00 am
12:00 pm
1:00 pm
2:00 pm
3:00 pm
4:00 pm
5:00 pm
6:00 pm
7:00 pm
8:00 pm
9:00 pm
10:00 pm
11:00 pm
11:25 am Invited Talk: “Inside-out” NF-kappa B signaling in cancer and other pathologies @ Acharya Hall
Invited Talk: “Inside-out” NF-kappa B signaling in cancer and other pathologies @ Acharya Hall
Aug 13 @ 11:25 am – 11:40 am
Invited Talk: “Inside-out” NF-kappa B signaling in cancer and other pathologies @ Acharya Hall | Vallikavu | Kerala | India
Shigeki Miyamoto, Ph.D. Professor, McArdle Laboratory for Cancer Research – UW Carbone Cancer Center Department of Oncology, School of Medicine and Public Health University of Wisconsin-Madison “Inside-out” NF-κB signaling in cancer and other pathologies The NF-κB/Rel family of transcription factors contributes to critical
11:50 am Invited Talk: Pertubation of DNA topology in mycobacteria @ Acharya Hall
Invited Talk: Pertubation of DNA topology in mycobacteria @ Acharya Hall
Aug 13 @ 11:50 am – 12:12 pm
Invited Talk: Pertubation of DNA topology in mycobacteria @ Acharya Hall | Vallikavu | Kerala | India
V. Nagaraja Ph.D. Professor, Indian Institute of Science, Bengaluru, India Perturbation of DNA topology in mycobacteria To maintain the topological homeostasis of the genome in the cell, DNA topoisomerases catalyse DNA cleavage, strand passage and rejoining of the ends. Thus,
3:26 pm Invited Talk: Probing Estrogen Receptor – Tumor Suppressor p53 Interaction in Cancer: From Basic Research to Clinical Trial @ Acharya Hall
Invited Talk: Probing Estrogen Receptor – Tumor Suppressor p53 Interaction in Cancer: From Basic Research to Clinical Trial @ Acharya Hall
Aug 13 @ 3:26 pm – 3:57 pm
Invited Talk: Probing Estrogen Receptor - Tumor Suppressor p53 Interaction in Cancer: From Basic Research to Clinical Trial @ Acharya Hall | Vallikavu | Kerala | India
Gokul Das, Ph.D. Co-Director, Breast Disease Site Research Group, Roswell Park Cancer Institute, Buffalo, NY Probing Estrogen Receptor−Tumor Suppressor p53 Interaction in Cancer: From Basic Research to Clinical Trial Tumor suppressor p53 and estrogen receptor have opposite roles in the
4:25 pm Invited Talk: Cancer Stem Cells – Target Colon Cancer @ Acharya Hall
Invited Talk: Cancer Stem Cells – Target Colon Cancer @ Acharya Hall
Aug 13 @ 4:25 pm – 5:04 pm
Invited Talk: Cancer Stem Cells – Target Colon Cancer @ Acharya Hall | Vallikavu | Kerala | India
Shrikant Anant, Ph.D. The Department of Molecular & Integrative Physiology, Kansas University Medical Center, USA Cancer Stem Cells: Target Colon Cancers Shrikant Anant, Deep Kwatra and Dharmalingam Subramaniam Colon cancer is a leading cause of cancer related deaths in the
6:26 pm Delegate Talk: A Non-toxic Approach to Prevent Secondary Effects of Chemotherapies @ Acharya Hall
Delegate Talk: A Non-toxic Approach to Prevent Secondary Effects of Chemotherapies @ Acharya Hall
Aug 13 @ 6:26 pm – 6:38 pm
Delegate Talk: A Non-toxic Approach to Prevent Secondary Effects of Chemotherapies @ Acharya Hall | Vallikavu | Kerala | India
Tanu Sharma, Narendra Parihar, Someshwar Nath, Azad Singh, Savneet Kaur, Simendra Singh and Chandi Mandal. In the recent years, there has been a surge in various forms of cancers especially in urban areas of India. Tumor recurrence and metastasis are
7:03 pm Delegate Talk: A proteomic approach to decipher the mechanism of action and molecular targets of curcumin in Bacillus subtilis @ Acharya Hall
Delegate Talk: A proteomic approach to decipher the mechanism of action and molecular targets of curcumin in Bacillus subtilis @ Acharya Hall
Aug 13 @ 7:03 pm – 7:13 pm
Delegate Talk: A proteomic approach to decipher the mechanism of action and molecular targets of curcumin in Bacillus subtilis @ Acharya Hall | Vallikavu | Kerala | India
Jaipal Panga Reddy, Dulal Panda and Sanjeeva Srivastava The rapid emergence of microbial resistance against the ever increasing number of infectious diseases has been a major hurdle in hunt for novel antibiotics and inventive targets required to combat these dreaded